Development and validation of a new reversed-phase HPLC method for the determination of ezetimibe in pharmaceutical dosage forms

Ghanshyam Panjwani, Ragvendra Shetty, Gautham Shenoy, Dinesh Dhamecha

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Ezetimibe belongs to a group of selective and very effective 2-azetidione cholesterol absorption inhibitors that act on the level of cholesterol entry into enterocytes. A new, rapid, specific reversed-phase HPLC method has been developed for assaying ezetimibe in pharmaceutical dosage forms. The assay involved an isocratic elution of ezetimibe in a Betasil C18 (250 mm x 4.6 mm i.d., 5μ) column using a mobile phase composition of 18 Acetonitrile: 10 mM Na2 HPO4 pH 7.0 (55:45 v/v). The flow rate was 1ml/min and the analyte monitored at 233nm. The assay method was found to be linear from 4-24μg/mL. All the validation parameters were within the acceptance range. The developed method was successfully applied to estimate the amount of ezetimibe in tablets.

Original languageEnglish
Pages (from-to)7-12
Number of pages6
JournalIndian Journal of Pharmaceutical Education and Research
Volume47
Issue number1
Publication statusPublished - 01-01-2013

Fingerprint

Dosage Forms
High Pressure Liquid Chromatography
Pharmaceutical Preparations
Anticholesteremic Agents
Enterocytes
Tablets
Cholesterol
Ezetimibe

All Science Journal Classification (ASJC) codes

  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

@article{2f66e304d4d7420b913372ef4fe51a26,
title = "Development and validation of a new reversed-phase HPLC method for the determination of ezetimibe in pharmaceutical dosage forms",
abstract = "Ezetimibe belongs to a group of selective and very effective 2-azetidione cholesterol absorption inhibitors that act on the level of cholesterol entry into enterocytes. A new, rapid, specific reversed-phase HPLC method has been developed for assaying ezetimibe in pharmaceutical dosage forms. The assay involved an isocratic elution of ezetimibe in a Betasil C18 (250 mm x 4.6 mm i.d., 5μ) column using a mobile phase composition of 18 Acetonitrile: 10 mM Na2 HPO4 pH 7.0 (55:45 v/v). The flow rate was 1ml/min and the analyte monitored at 233nm. The assay method was found to be linear from 4-24μg/mL. All the validation parameters were within the acceptance range. The developed method was successfully applied to estimate the amount of ezetimibe in tablets.",
author = "Ghanshyam Panjwani and Ragvendra Shetty and Gautham Shenoy and Dinesh Dhamecha",
year = "2013",
month = "1",
day = "1",
language = "English",
volume = "47",
pages = "7--12",
journal = "Indian Journal of Pharmaceutical Education and Research",
issn = "0019-5464",
publisher = "Association of Pharmaceutical Teachers of India",
number = "1",

}

Development and validation of a new reversed-phase HPLC method for the determination of ezetimibe in pharmaceutical dosage forms. / Panjwani, Ghanshyam; Shetty, Ragvendra; Shenoy, Gautham; Dhamecha, Dinesh.

In: Indian Journal of Pharmaceutical Education and Research, Vol. 47, No. 1, 01.01.2013, p. 7-12.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Development and validation of a new reversed-phase HPLC method for the determination of ezetimibe in pharmaceutical dosage forms

AU - Panjwani, Ghanshyam

AU - Shetty, Ragvendra

AU - Shenoy, Gautham

AU - Dhamecha, Dinesh

PY - 2013/1/1

Y1 - 2013/1/1

N2 - Ezetimibe belongs to a group of selective and very effective 2-azetidione cholesterol absorption inhibitors that act on the level of cholesterol entry into enterocytes. A new, rapid, specific reversed-phase HPLC method has been developed for assaying ezetimibe in pharmaceutical dosage forms. The assay involved an isocratic elution of ezetimibe in a Betasil C18 (250 mm x 4.6 mm i.d., 5μ) column using a mobile phase composition of 18 Acetonitrile: 10 mM Na2 HPO4 pH 7.0 (55:45 v/v). The flow rate was 1ml/min and the analyte monitored at 233nm. The assay method was found to be linear from 4-24μg/mL. All the validation parameters were within the acceptance range. The developed method was successfully applied to estimate the amount of ezetimibe in tablets.

AB - Ezetimibe belongs to a group of selective and very effective 2-azetidione cholesterol absorption inhibitors that act on the level of cholesterol entry into enterocytes. A new, rapid, specific reversed-phase HPLC method has been developed for assaying ezetimibe in pharmaceutical dosage forms. The assay involved an isocratic elution of ezetimibe in a Betasil C18 (250 mm x 4.6 mm i.d., 5μ) column using a mobile phase composition of 18 Acetonitrile: 10 mM Na2 HPO4 pH 7.0 (55:45 v/v). The flow rate was 1ml/min and the analyte monitored at 233nm. The assay method was found to be linear from 4-24μg/mL. All the validation parameters were within the acceptance range. The developed method was successfully applied to estimate the amount of ezetimibe in tablets.

UR - http://www.scopus.com/inward/record.url?scp=84880951247&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84880951247&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:84880951247

VL - 47

SP - 7

EP - 12

JO - Indian Journal of Pharmaceutical Education and Research

JF - Indian Journal of Pharmaceutical Education and Research

SN - 0019-5464

IS - 1

ER -